Insider · CIK 0002064777
Zung Phuong To
Files at KZR (Kezar Life Sciences, Inc.). First filing -, latest -.
Zung Phuong To files SEC Form 4 as officer at KZR (Kezar Life Sciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Zung Phuong To has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | KZR Kezar Life Sciences, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +7,000 | $0.00 | $0 | 7,000 | Jul 1, 2025 |
Questions about Zung Phuong To
Answered from the filings on this page, as of the latest one.
Is Zung Phuong To buying or selling?
Zung Phuong To has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Zung Phuong To's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Zung Phuong To has 0.
Where does Zung Phuong To file Form 4?
Zung Phuong To has filed Form 4 at KZR (Kezar Life Sciences, Inc.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.